| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |